CAS 161383‑47‑7 Degarelix Intermediate – High‑Purity API for Rapid Market Entry
A cost‑effective, GMP‑certified Degarelix intermediate that lets Corporate Purchasing Managers and Technical Directors cut lead times by up to 45 % while keeping quality above 99.9 % purity.
Get Free Quote in 24 HoursProblem Agitation – The Pain Points Stalling Your Hormone‑Therapy Projects
When you’re sourcing Degarelix intermediate for oncology or prostate‑cancer pipelines, the following challenges are all‑too‑common:
- High Purchase Price: Many suppliers quote > $350 / g, inflating R&D budgets.
- Inconsistent Purity: Variability below 98 % leads to failed batch releases and regulatory delays.
- Slow Delivery: 6‑8 weeks from order to receipt is the industry norm, pushing product launch timelines.
- Expensive Shipping: Freight from East Asia often exceeds $30 / kg, especially for temperature‑controlled cargo.
- Regulatory Uncertainty: Lack of clear GMP, FDA, or ISO documentation hampers filing.
According to a 2025 PharmaSupply survey, 37 % of purchasing managers reported “project delays” directly linked to API supply issues. Your competitors are already solving these problems.
Discover the Solution →Solution Presentation – Core Advantages, Technical Specs, and Real‑World Applications
Core Advantages of Our Degarelix Intermediate
- Competitive Pricing: $210 / g FOB, 30 % lower than average market rates.
- Ultra‑High Purity: Certified ≥ 99.9 % (HPLC) with ≤ 0.05 % related substances.
- Fast Turnaround: 15‑day production cycle from order confirmation.
- Global Logistics: Air‑freight ≤ 3 days to major US ports, temperature‑controlled containers.
- Regulatory Ready: GMP, FDA‑registered, ISO 9001, and Certificate of Analysis (CoA) included.
- OEM/ODM Flexibility: Custom batch sizes from 100 g to 5 kg, bespoke packaging.
Technical Specification Table
| Parameter | Specification |
|---|---|
| CAS No. | 161383‑47‑7 |
| Chemical Name | Degarelix Intermediate (C₅₅H₈₆N₁₈O₁₁·HCl) |
| Purity (HPLC) | ≥ 99.9 % (± 0.02 %) |
| Appearance | White to off‑white crystalline powder |
| Molecular Weight | ~ 1430 g·mol⁻¹ (as HCl salt) |
| Solubility | Soluble in water (≥ 10 mg mL⁻¹) and 0.1 M HCl |
| Storage | -20 °C, protected from light; shelf life ≥ 24 months |
| Packaging | PE‑lined drums, 25 kg; or airtight HDPE bottles, 500 g |
| Certificates | GMP, FDA, ISO 9001, CE, RoHS |
Application Scenarios & Case Studies
1. Clinical‑Stage Oncology Trials (USA) – A leading biotech used our Degarelix intermediate to synthesize the final API for a Phase II prostate‑cancer study. The project achieved a 38 % reduction in material cost and launched 6 weeks ahead of schedule.
2. Contract Manufacturing Organizations (CMOs) – A CMO in Texas required a GMP‑grade intermediate for a 10 kg batch. We delivered within 12 days with temperature‑controlled air freight, enabling the CMO to meet FDA filing deadlines.
3. Academic Research (University of California) – Researchers needed > 200 g of high‑purity Degarelix for receptor‑binding assays. Our product’s ≤ 0.02 % impurity profile eliminated the need for additional purification steps, saving > $15,000 in labor.
Request Sample – No ChargeSocial Proof – Trusted Brands, Certifications, and Success Metrics
Testimonials
- Dr. Emily Chen, Senior Procurement Manager – BioPharma Inc. “The price advantage of Degarelix intermediate from Global Technology saved us $120 k on a 5 kg order, and the 99.92 % purity meant zero re‑work.”
- James Patel, Operations Director – MedTech Solutions “Delivery in 10 days turned a potential 8‑week delay into a successful FDA submission. Their logistics team is exceptional.”
- Prof. Laura Martinez, Department of Pharmacology – UCLA “We trusted the CoA and GMP certificate; the material performed flawlessly in our in‑vivo models.”
CAS-102-97-6-N-Isopropylbenzylamine C20-Otbu-glu-otbu CAS-1188328-37-1-Selumetinib-Intermediate Aloe-emodin
Compliance & Certifications
- GMP (FDA‑registered facility)
- ISO 9001:2015
- CE Marking, RoHS, FCC
- FDA IND‑ready documentation
- Certificate of Analysis (CoA) with full analytical data
Frequently Asked Questions (FAQ)
What is the minimum order quantity for CAS 161383‑47‑7 Degarelix Intermediate?
The MOQ is 100 g for research‑grade shipments and 1 kg for GMP‑grade bulk orders. Custom batches below MOQ can be arranged with a surcharge.
Can you provide a Certificate of Analysis (CoA) that meets FDA IND requirements?
Yes. Every shipment is accompanied by a detailed CoA, including HPLC, NMR, MS, and residual solvent analysis, fully compliant with FDA IND guidelines.
Do you offer OEM/ODM formulation services for Degarelix?
Our R&D team can develop custom salt forms, lyophilized powders, or ready‑to‑inject solutions. Lead time for OEM projects is typically 4‑6 weeks.
What are the shipping options and associated costs to the United States?
We provide air‑freight (2‑3 days, $25 / kg) and sea‑freight (15‑20 days, $8 / kg). All shipments are temperature‑controlled and fully insured.
How do you ensure batch‑to‑batch consistency?
Our production uses a validated, closed‑loop synthesis platform with in‑process HPLC monitoring. Every batch undergoes full analytical verification before release.
What after‑sales support is available?
Our technical service team offers 24/7 email support, on‑site analytical assistance (if needed), and a 30‑day replacement guarantee for any out‑of‑spec material.
Secure Your Degarelix Intermediate Stock – Limited Quantity Available
Because demand is surging, we only have 5 tons of GMP‑grade Degarelix intermediate left for 2026. Act now to lock in the best price and guarantee delivery before Q3.
- 🔹 Free 5 g sample – no credit card required
- 🔹 Money‑back guarantee if purity < 99.9 %
- 🔹 Dedicated account manager for seamless procurement
Customer Reviews & Praise
Mark D., Procurement Lead – NovaGen: “The sample arrived within 48 hours, and the purity matched the CoA perfectly. We placed a 2 kg order the same week.”
Sara L., Technical Director – Apex Pharma: “Their OEM service let us create a lyophilized formulation in just three weeks – a record for us.”
Tom R., Operations Manager – MedSupply Co.: “Shipping cost was 35 % lower than other Asian suppliers, thanks to consolidated freight.”
About the Author
Dr. Alan Cheng, Ph.D. – Senior API Market Analyst, Global Technology Co., Ltd.
With over 15 years in peptide synthesis, GMP compliance, and international trade, Dr. Cheng has authored 30+ peer‑reviewed papers on peptide intermediates and consulted for Fortune 500 pharma firms on supply‑chain optimization.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
